Nutriband (NTRB)
Develops transdermal drug products centered on its AVERSA abuse-deterrent patch technology.
$6.85
After-hours close−0.10 (−1.44%)
At close$6.95(−10.55%)
Something off on this page? Send us feedback.
Next report
Dec 7, 26
estimated · in 76 days
EPS estimate
—
Revenue estimate
$449.2K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Sep '25Dec '25Apr '26Jun '26Sep '26Dec '26
Reported−$0.50−$0.12−$2.12−$0.12−$0.04−$0.10−$0.07Pending
Estimate−$0.12−$0.13−$0.17−$2.13−$1.89−$1.89——
Surprise−316.7%+7.7%−1,147.1%+94.4%+97.9%+94.7%——
RevenueReportedEstimate
Apr '25May '25Sep '25Dec '25Apr '26Jun '26Sep '26Dec '26
Reported$642.0K$667.0K$622.0K$346.1K$400.7K$433.4K$437.5KPending
Estimate$642.0K$667.0K$622.0K$675.0K$765.0K$765.0K$437.5K$449.2K
Surprise0.0%0.0%0.0%−48.7%−47.6%−43.3%0.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | $0.00 | — | — |
| Sep 2026 | — | −$0.07 | — |
| Jun 2026 | −$1.89 | −$0.10 | +94.7% |
| Apr 2026 | −$1.89 | −$0.04 | +97.9% |
| Dec 2025 | −$2.13 | −$0.12 | +94.4% |
| Sep 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Dec 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Apr 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Apr 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Apr 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Apr 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Apr 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| May 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| May 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Apr 2016 | |||
| Jan 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 7, 2026 | $0.00 | — | — | $449.2K | — | — | — |
| Sep 4, 2026 | — | −$0.07 | — | $437.5K | $437.5K | 0.0% | +6.0% |
| Jun 11, 2026 | −$1.89 | −$0.10 | +94.7% | $765.0K | $433.4K | −43.3% | +3.2% |
| Apr 29, 2026 | −$1.89 | −$0.04 | +97.9% | $765.0K | $400.7K | −47.6% | +2.1% |
| Dec 16, 2025 | −$2.13 | −$0.12 | +94.4% | $675.0K | $346.1K | −48.7% | −7.2% |
| Sep 9, 2025 | |||||||
| May 30, 2025 | |||||||
| Apr 28, 2025 | |||||||
| Dec 3, 2024 | |||||||
| Sep 3, 2024 | |||||||
| May 31, 2024 | |||||||
| Apr 30, 2024 | |||||||
| Dec 12, 2023 | |||||||
| Sep 11, 2023 | |||||||
| Jun 9, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Dec 2, 2022 | |||||||
| Sep 7, 2022 | |||||||
| May 31, 2022 | |||||||
| Apr 29, 2022 | |||||||
| Dec 14, 2021 | |||||||
| Sep 3, 2021 | |||||||
| Jun 14, 2021 | |||||||
| Apr 2, 2021 | |||||||
| Dec 15, 2020 | |||||||
| Sep 11, 2020 | |||||||
| Jun 4, 2020 | |||||||
| Apr 14, 2020 | |||||||
| Dec 12, 2019 | |||||||
| Sep 12, 2019 | |||||||
| Jun 13, 2019 | |||||||
| Apr 19, 2019 | |||||||
| Dec 14, 2018 | |||||||
| Sep 17, 2018 | |||||||
| Jun 18, 2018 | |||||||
| May 1, 2018 | |||||||
| Dec 8, 2017 | |||||||
| Sep 19, 2017 | |||||||
| Jun 19, 2017 | |||||||
| May 5, 2017 | |||||||
| Dec 13, 2016 | |||||||
| Sep 14, 2016 | |||||||
| Apr 30, 2016 | |||||||
| Jan 31, 2016 |